跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Convult - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Convult
Approved
STANDARD
Convult
Stallion Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
17c06641eb45a709
Company
Stallion Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
17c06641eb45a709
Drug Approval Philippines Name
Convult
Product Name
Convult
Registration Number
DRP-8750
Brand Name
Convult
Generic Name
Pregabalin
Dosage Form
Capsule
Dosage Strength
75mg
Manufacturer
Stallion Laboratories Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Issuance Date
25 March 2024
Expiry Date
21 February 2030
Pharmacologic Category
Anti-epileptic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
17c06641eb45a709
Type
Standard
Back to Philippines FDA Approvals